The independent source for health policy research, polling, and news.
561-580 of 1,239 results
Federal officials are offering $75 to dairy workers who agree to be tested for bird flu. Advocates say the payments aren’t enough to protect workers from lost wages and health care costs if they test positive.
Ballad Health, a 20-hospital system in Tennessee and Virginia, benefits from the largest state-sanctioned hospital monopoly in the United States and is the only option for hospital care for a large swath of Appalachia.
Mounting evidence suggests psychoactive drugs including LSD, ketamine, mushrooms, and MDMA can be powerful treatments for severe depression and PTSD. But not everyone is convinced. And even if such drugs gain FDA approval, safety protocols could render them extremely expensive.
A Florida law was enacted this spring making the Sunshine State the first in the nation to let cesarean sections be performed in settings other than hospitals — leading to warnings about increased risks for pregnant women and their babies.
A single Central Florida county reported 13% of all U.S. leprosy cases in 2020. Researchers have teamed up to investigate whether armadillos are passing the bacteria that cause the disease to humans — which is especially concerning as the animals expand their range farther north.
Dairy farmers and veterinarians in northern Texas furiously investigated a mysterious illness among cattle before the government got involved. Their observations are telling.
A man from Michigan was evacuated from a cruise ship after having seizures. First, he drained his bank account to pay his medical bills.
The makers of Ozempic and Mounjaro charge list prices of around $1,000 a month for the diabetes and obesity drugs, and insurers are reluctant to pick up the tab. Often, low-income patients have to resort to less effective treatments.
Hundreds of Native American tribes are getting money from settlements with companies that made or sold prescription painkillers. Some are investing it in sweat lodges, statistical models, and insurance-billing staffers.
People with disabilities say they are abruptly losing their Medicaid home health benefits and are being advised incorrectly when they call state offices for more information. “Every day the anxiety builds,” one beneficiary told KFF Health News.
Johns Dental Laboratories stopped making the Anterior Growth Guidance Appliance last year after a KFF Health News-CBS News investigation into allegations of patient harm. The company had “never” reported any complaints about its products to the FDA, according to the agency.
A new analysis shows that students graduating from U.S. medical schools were less likely to apply this year for residency positions in states with abortion bans and other significant abortion restrictions.
Dozens of hospitals have deployed a device that uses artificial intelligence to monitor patients remotely. One hospital says it reduces nurses’ workloads — but some nurses fear the technology could replace them.
Federal regulators face a growing challenge — how to prevent rogue health insurance agents from switching unknowing consumers’ Obamacare coverage without making the enrollment process so cumbersome that enrollment declines.
A decade after Congress told the FDA to expedite the approval of more effective sunscreens, the federal government still has not approved sunscreen ingredients that are safely being used around the world. Meanwhile, skin cancer is the nation’s most common cancer.
KFF Health News and California Healthline staffers made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Cattle across the country are infected by the H5N1 bird flu. The virus isn’t spreading among people — but if it evolves to do that, fears of another pandemic could be realized.
A six-week abortion ban took effect in Florida this week, dramatically restricting access to the procedure not just in the nation’s third-most-populous state but across the South. Patients from states with even more restrictive bans had been flooding in since the overturn of Roe v. Wade in 2022. Meanwhile, the CEO of the health behemoth UnitedHealth Group appeared before committees in both the House and Senate, where lawmakers grilled him about the February cyberattack on subsidiary Change Healthcare and how its ramifications are being felt months later. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Rachana Pradhan of KFF Health News join KFF Health News’ Julie Rovner to discuss these stories and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too.
© 2026 KFF